Physician profile
Philip E Blazar
NPI 1497733158
$20,781.56
in general payments reported to CMS, 2019-2025
11 companies · $2,903 in 2025
The $2,903 reported for 2025 was more than what 87% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $33.41 · 2021: $3,513 · 2022: $3,490 · 2023: $241 · 2024: $10K · 2025: $2,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,537.00 |
| Food and Beverage | $1,712.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $11,206.85 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $7,404.08 | 2024-2025 | Xiaflex |
| Synthes Gmbh | $750.00 | 2021-2022 | |
| Trimed, INC. | $743.97 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $213.92 | 2019-2024 | A.L.P.S. |
| Axogen | $146.93 | 2025 | |
| Acumed LLC | $100.00 | 2019 | |
| Medical Device Business Services, INC. | $96.33 | 2023-2025 | Va-Lcp |
| Alnylam Pharmaceuticals INC. | $67.50 | 2024 | Onpattro |
| Sonex Health, INC. | $33.41 | 2020 | |
| Kairos Surgical INC | $18.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Blazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.